The Leipzig TAVI Registry
ConditionAortic Valve Stenosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHelios Health Institute GmbH
About this trial
A single-center registry including all patients treated with TAVI at the Heart Center, Leipzig, Germany
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients treated with TAVI
Disqualifiers
None
Trial population
All comers patient population treated with TAVI
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Transcatheter Aortic Valve Implantation
DeviceInterventional replacement of the aortic valve
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Mortality
Cardiovascular and not cardiovascular death 1. identify the current incidence of periprocedural complications. 2. identification of risk groups 3. description of the long-term outcome with special attention to the durability of the different prostheses
Time frame
Up to 10 yearsSecondary outcomes
1
Structural valve deterioration
Transposthetic mean pressure gradient ≥ 40mmHg and/or ≥20mmHg rise from baseline OR severe intraprosthetic aortic regurgitation
Time frame
Up to 10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov